GLENMARK PHARMACEUTICALS
Back to All Ratios
|
GLENMARK PHARMACEUTICALS Last 5 Year Core EBITDA Margin History
[Consolidated]
Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 | |
---|---|---|---|---|---|
Core EBITDA Margin(%) | 7.69 | 8.35 | 8.26 | 15.96 | 16.07 |
What is the latest Core EBITDA Margin ratio of GLENMARK PHARMACEUTICALS ?
Year | Core EBITDA Margin |
---|---|
Mar2023 | 7.69 |
Mar2022 | 8.35 |
Mar2021 | 8.26 |
Mar2020 | 15.96 |
Mar2019 | 16.07 |
How is Core EBITDA Margin of GLENMARK PHARMACEUTICALS Trending?
Years | Core EBITDA Margin | % Change | |
---|---|---|---|
Mar2023 | 7.69 | -7.90 | |
Mar2022 | 8.35 | 1.09 | |
Mar2021 | 8.26 | -48.25 | |
Mar2020 | 15.96 | -0.68 | |
Mar2019 | 16.07 | - |
Other Financial Ratios of GLENMARK PHARMACEUTICALS
Operational & Financial Ratios Earnings Per Share CEPS DPS Book NAV/Share Tax Rate | Margin Ratios EBIT Margin Pre Tax Margin PAT Margin Cash Profit Margin | Performance Ratios ROA ROE ROCE Asset Turnover Sales/Fixed Asset Working Capital/Sales | Efficiency Ratios Fixed Capital/Sales Receivable days Inventory Days Payable days | Valuation Parameters PER PCE Price/Book Yield EV/Net Sales EV/Core EBITDA EV/EBIT EV/CE M Cap / Sales | Growth Ratios Net Sales Growth Core EBITDA Growth EBIT Growth PAT Growth EPS Growth | Financial Stability Ratios Total Debt/Equity Current Ratio Quick Ratio Interest Cover Total Debt/Mcap |
Compare Core EBITDA Margin ratio of peers of GLENMARK PHARMACEUTICALS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
GLENMARK PHARMACEUTICALS | ₹29,927.3 Cr | -1.8% | 10.8% | 91.6% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹364,315.0 Cr | -0.1% | -6.3% | 53.5% | Stock Analytics | |
CIPLA | ₹114,614.0 Cr | 1% | -5% | 53.3% | Stock Analytics | |
DIVIS LABORATORIES | ₹105,233.0 Cr | 3.2% | 15.3% | 23.6% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹104,900.0 Cr | 1.1% | 2.2% | 26% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹99,426.0 Cr | 3.9% | -1.7% | 85.2% | Stock Analytics |
GLENMARK PHARMACEUTICALS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
GLENMARK PHARMACEUTICALS | -1.8% |
10.8% |
91.6% |
SENSEX | 1% |
2.2% |
23.7% |
You may also like the below Video Courses